Treatment of MCF-7 breast cancer cells with BRCA1 + NP and BRCA2 + NP was linked with de-phosphorylation (deactivated form) of MAPK without an alteration in the total MAPK level (Fig. 4a). The gene discussed is BRCA2; the disease is breast carcinoma.